Literature DB >> 12512960

Neurotensin effect on Na+, K+-ATPase is CNS area- and membrane-dependent and involves high affinity NT1 receptor.

María Graciela López Ordieres1, Georgina Rodríguez de Lores Arnaiz.   

Abstract

We have previously shown that peptide neurotensin inhibits cerebral cortex synaptosomal membrane Na+, K+-ATPase, an effect fully prevented by blockade of neurotensin NT1 receptor by antagonist SR 48692. The work was extended to analyze neurotensin effect on Na+, K+-ATPase activity present in other synaptosomal membranes and in CNS myelin and mitochondrial fractions. Results indicated that, besides inhibiting cerebral cortex synaptosomal membrane Na+, K+-ATPase, neurotensin likewise decreased enzyme activity in homologous striatal membranes as well as in a commercial preparation obtained from porcine cerebral cortex. However, the peptide failed to alter either Na+, K+-ATPase activity in cerebellar synaptosomal and myelin membranes or ATPase activity in mitochondrial preparations. Whenever an effect was recorded with the peptide, it was blocked by antagonist SR 48692, indicating the involvement of the high affinity neurotensin receptor (NT1), as well as supporting the contention that, through inhibition of ion transport at synaptic membrane level, neurotensin plays a regulatory role in neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12512960     DOI: 10.1023/a:1021612825025

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  35 in total

Review 1.  How many endobains are there?

Authors:  G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 2.  Distribution of neurotensin receptors in mammalian brain. What it is telling us about its interactions with other neurotransmitter systems.

Authors:  R Quirion; W B Rowe; P A Lapchak; D M Araujo; A Beaudet
Journal:  Ann N Y Acad Sci       Date:  1992       Impact factor: 5.691

Review 3.  Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin.

Authors:  K Fuxe; G Von Euler; L F Agnati; E Merlo Pich; W T O'Connor; S Tanganelli; X M Li; B Tinner; A Cintra; C Carani
Journal:  Ann N Y Acad Sci       Date:  1992       Impact factor: 5.691

4.  Insulin modifies Na(+), K(+)-ATPase activity of synaptosomal membranes and whole homogenates prepared from rat cerebral cortex.

Authors:  G Bojorge; G R de Lores Arnaiz
Journal:  Neurochem Int       Date:  1987       Impact factor: 3.921

5.  Regulation of (Na+, K+) adenosinetriphosphatase of nerve ending membranes: action of norepinephrine and a soluble factor.

Authors:  G Rodriguez De Lores Arnaiz; M Mistrorigo De Pacheco
Journal:  Neurochem Res       Date:  1978-12       Impact factor: 3.996

6.  A study of calcitonin effect on synaptosomal membrane enzymes.

Authors:  G Rodríguez de Lores Arnaiz; M G López Ordieres
Journal:  Peptides       Date:  1997       Impact factor: 3.750

7.  K(+)-p-nitrophenylphosphatase inhibition by neurotensin involves high affinity neurotensin receptor: influence of potassium concentration and enzyme phosphorylation.

Authors:  M G López Ordieres; G Rodríguez de Lores Arnaiz
Journal:  Regul Pept       Date:  2001-09-15

8.  Effect of angiotensin-(1-7) on ATPase activities in several tissues.

Authors:  M G López Ordieres; M Gironacci; G Rodríguez de Lores Arnaiz; C Peña
Journal:  Regul Pept       Date:  1998-10-16

9.  Actions of neurotensin: a review of the electrophysiological studies.

Authors:  W X Shi; B S Bunney
Journal:  Ann N Y Acad Sci       Date:  1992       Impact factor: 5.691

10.  Neurotensin depolarizes substantia nigra dopamine neurones.

Authors:  R D Pinnock
Journal:  Brain Res       Date:  1985-07-08       Impact factor: 3.252

View more
  1 in total

1.  High-affinity neurotensin receptor is involved in phosphoinositide turnover increase by inhibition of sodium pump in neonatal rat brain.

Authors:  Susana Pereyra-Alfonso; María Del Valle Armanino; Carolina Vázquez; Clara Peña; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2008-08-29       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.